Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
B. Riley Financial, Inc. (RILY)
|
Add to portfolio |
|
|
|
| Price: |
$69.30
| | Metrics |
| OS: |
30.6
|
M
| |
10
|
% ROE
|
| Market cap: |
$2.12
|
B
| |
6
|
% ROIC
|
|
Net debt:
|
$5.11
|
B
| |
11.3
|
x Debt/EBITDA
|
|
EV:
|
$7.22
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$453
|
M
| |
15.9
|
x EV/EBITDA
|
|
EBIT
|
$403
|
M
| |
17.9
|
x EV/EBIT
|
| EPS |
$1.51
| |
45.9
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 962.2 | 1,179.4 | 665.3 | 458.5 | 384.6 | 322.2 | 190.4 | 112.5 |
| Revenue growth | -18.4% | 77.3% | 45.1% | 19.2% | 19.4% | 69.3% | 69.2% | 45.9% |
| Cost of goods sold | 221.1 | 81.3 | 72.9 | 66.4 | 35.6 | 41.0 | 55.6 | 32.1 |
| Gross profit | 741.1 | 1,098.0 | 592.4 | 392.1 | 349.1 | 281.2 | 134.7 | 80.4 |
| Gross margin | 77.0% | 93.1% | 89.0% | 85.5% | 90.8% | 87.3% | 70.8% | 71.5% |
| Selling, general and administrative | 714.6 | 906.2 | 428.5 | 385.2 | 310.5 | 227.9 | 82.1 | 58.3 |
| EBIT | 82.0 | 517.3 | 289.7 | 166.9 | 53.9 | 46.8 | 52.6 | 22.1 |
| EBIT margin | 8.5% | 43.9% | 43.5% | 36.4% | 14.0% | 14.5% | 27.6% | 19.6% |
| Pre-tax income | -220.5 | 614.8 | 279.5 | 116.6 | 21.3 | 20.4 | 47.0 | 21.3 |
| Income taxes | -63.9 | 164.0 | 75.4 | -34.6 | 4.9 | 8.5 | 14.3 | 7.7 |
| Tax rate | 29.0% | 26.7% | 27.0% | | 23.0% | 41.6% | 30.4% | 36.2% |
| Net income | -167.8 | 437.6 | 200.4 | 81.3 | 15.5 | 11.6 | 21.5 | 11.8 |
| Net margin | -17.4% | 37.1% | 30.1% | 17.7% | 4.0% | 3.6% | 11.3% | 10.5% |
| |
| Diluted EPS | ($5.95) | $15.09 | $7.56 | $2.95 | $0.58 | $0.48 | $1.17 | $0.73 |
| Shares outstanding (diluted) | 28.2 | 29.0 | 26.5 | 27.5 | 26.8 | 24.3 | 18.4 | 16.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|